181 related articles for article (PubMed ID: 11387323)
21. Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1.
Becamel C; Figge A; Poliak S; Dumuis A; Peles E; Bockaert J; Lubbert H; Ullmer C
J Biol Chem; 2001 Apr; 276(16):12974-82. PubMed ID: 11150294
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors.
Knauer CS; Campbell JE; Chio CL; Fitzgerald LW
Naunyn Schmiedebergs Arch Pharmacol; 2009 May; 379(5):461-71. PubMed ID: 19057895
[TBL] [Abstract][Full Text] [Related]
23. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
[TBL] [Abstract][Full Text] [Related]
24. 5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes.
Derangeon M; Bozon V; Defamie N; Peineau N; Bourmeyster N; Sarrouilhe D; Argibay JA; Hervé JC
J Mol Cell Cardiol; 2010 Jan; 48(1):220-9. PubMed ID: 19615378
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat.
Watts SW; Thompson JM
J Pharmacol Exp Ther; 2004 Apr; 309(1):165-72. PubMed ID: 14724222
[TBL] [Abstract][Full Text] [Related]
26. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.
Bliziotes M; Eshleman A; Burt-Pichat B; Zhang XW; Hashimoto J; Wiren K; Chenu C
Bone; 2006 Dec; 39(6):1313-21. PubMed ID: 16884969
[TBL] [Abstract][Full Text] [Related]
27. Functional serotonin 5-HT1D receptors and 5-HT1D beta receptor mRNA expression in human umbilical vein endothelial cells.
Schoeffter P; Ullmer C; Gutierrez M; Weitz-Schmidt G; Lübbert H
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):580-2. PubMed ID: 8751089
[TBL] [Abstract][Full Text] [Related]
28. Mesenteric vasoconstrictor response to 5-hydroxytryptamine in the in situ blood autoperfused rat mesentery: involvement of 5-HT(2B) and/or 5-HT(2C) receptor activation.
Fernández MM; Morán A; Martín ML; San Román L
Eur J Pharmacol; 2000 Aug; 401(2):221-7. PubMed ID: 10924930
[TBL] [Abstract][Full Text] [Related]
29. The 5-HT(2C/2B) receptor agonist, m-chlorophenylpiperazine, increases plasma glucagon levels in rats.
Yamada J; Sugimoto Y
Eur J Pharmacol; 2000 Oct; 406(1):153-7. PubMed ID: 11011047
[TBL] [Abstract][Full Text] [Related]
30. Serotonin receptor 5-HT2B mediates serotonin-induced mechanical hyperalgesia.
Lin SY; Chang WJ; Lin CS; Huang CY; Wang HF; Sun WH
J Neurosci; 2011 Jan; 31(4):1410-8. PubMed ID: 21273425
[TBL] [Abstract][Full Text] [Related]
31. Serotonergic 5-HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase C.
Baudry A; Bitard J; Mouillet-Richard S; Locker M; Poliard A; Launay JM; Kellermann O
J Biol Chem; 2010 Aug; 285(34):26066-73. PubMed ID: 20573958
[TBL] [Abstract][Full Text] [Related]
32. Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation.
De Deurwaerdère P; Spampinato U
J Neurochem; 1999 Sep; 73(3):1033-42. PubMed ID: 10461892
[TBL] [Abstract][Full Text] [Related]
33. Vasoconstrictor responses to 5-hydroxytryptamine in the autoperfused hindquarters of spontaneously hypertensive rats.
Calama E; Morán A; Ortiz de Urbina AV; Martín ML; San Román L
Pharmacology; 2004 Jun; 71(2):66-72. PubMed ID: 15118345
[TBL] [Abstract][Full Text] [Related]
34. Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.
Xu J; Jian B; Chu R; Lu Z; Li Q; Dunlop J; Rosenzweig-Lipson S; McGonigle P; Levy RJ; Liang B
Am J Pathol; 2002 Dec; 161(6):2209-18. PubMed ID: 12466135
[TBL] [Abstract][Full Text] [Related]
35. Serotonin increases ERK1/2 phosphorylation in astrocytes by stimulation of 5-HT2B and 5-HT2C receptors.
Li B; Zhang S; Li M; Hertz L; Peng L
Neurochem Int; 2010 Nov; 57(4):432-9. PubMed ID: 20450948
[TBL] [Abstract][Full Text] [Related]
36. Serotonin-2B/2C Receptors Mediate Bovine Ciliary Muscle Contraction: Role in Intraocular Pressure Regulation.
Ohia SE; Njie-Mbye YF; Robinson J; Mitchell L; Mckoy M; Opere CA; Sharif NA
J Ocul Pharmacol Ther; 2018; 34(1-2):70-75. PubMed ID: 29364761
[TBL] [Abstract][Full Text] [Related]
37. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.
Bonhaus DW; Bach C; DeSouza A; Salazar FH; Matsuoka BD; Zuppan P; Chan HW; Eglen RM
Br J Pharmacol; 1995 Jun; 115(4):622-8. PubMed ID: 7582481
[TBL] [Abstract][Full Text] [Related]
38. The bulky N6 substituent of cabergoline is responsible for agonism of this drug at 5-hydroxytryptamine 5-HT2A and 5-HT2B receptors and thus is a determinant of valvular heart disease.
Kekewska A; Hübner H; Gmeiner P; Pertz HH
J Pharmacol Exp Ther; 2011 Jul; 338(1):381-91. PubMed ID: 21518772
[TBL] [Abstract][Full Text] [Related]
39. Role of 5-HT(2) receptors in the tryptamine-induced 5-HT syndrome in rats.
Van Oekelen D; Megens A; Meert T; Luyten WH; Leysen JE
Behav Pharmacol; 2002 Jul; 13(4):313-8. PubMed ID: 12218512
[TBL] [Abstract][Full Text] [Related]
40. Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors.
Popa D; Léna C; Fabre V; Prenat C; Gingrich J; Escourrou P; Hamon M; Adrien J
J Neurosci; 2005 Dec; 25(49):11231-8. PubMed ID: 16339018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
